CN115624509A - 一种极地抗衰组合物 - Google Patents
一种极地抗衰组合物 Download PDFInfo
- Publication number
- CN115624509A CN115624509A CN202211417613.6A CN202211417613A CN115624509A CN 115624509 A CN115624509 A CN 115624509A CN 202211417613 A CN202211417613 A CN 202211417613A CN 115624509 A CN115624509 A CN 115624509A
- Authority
- CN
- China
- Prior art keywords
- extract
- polar
- lichen
- composition
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 239000000284 extract Substances 0.000 claims abstract description 81
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000002994 raw material Substances 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000003755 preservative agent Substances 0.000 claims abstract description 20
- 230000002335 preservative effect Effects 0.000 claims abstract description 20
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 19
- 229920001436 collagen Polymers 0.000 claims abstract description 19
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 19
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 19
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 18
- 241000196324 Embryophyta Species 0.000 claims abstract description 17
- 241001116500 Taxus Species 0.000 claims abstract description 11
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 19
- 108010087806 Carnosine Proteins 0.000 claims description 19
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 19
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 19
- 229940044199 carnosine Drugs 0.000 claims description 19
- 241000220317 Rosa Species 0.000 claims description 18
- 239000013535 sea water Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 241000218657 Picea Species 0.000 claims description 14
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 13
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 13
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 238000004140 cleaning Methods 0.000 claims description 8
- 235000008124 Picea excelsa Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000001256 steam distillation Methods 0.000 claims description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- 230000003187 abdominal effect Effects 0.000 claims description 2
- -1 caprylyl hydroxamic Chemical compound 0.000 claims description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 2
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 241000202349 Taxus brevifolia Species 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 7
- 230000003020 moisturizing effect Effects 0.000 abstract description 5
- 230000000052 comparative effect Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 240000003241 Silphium laciniatum Species 0.000 description 9
- 235000009543 Silphium laciniatum Nutrition 0.000 description 9
- 230000032683 aging Effects 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 241000195493 Cryptophyta Species 0.000 description 5
- 229940102480 bilberry extract Drugs 0.000 description 5
- 235000019209 bilberry extract Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 241000533950 Leucojum Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- CUCUKLJLRRAKFN-UHFFFAOYSA-N 7-Hydroxy-(S)-usnate Chemical compound CC12C(=O)C(C(=O)C)C(=O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O CUCUKLJLRRAKFN-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 102000019040 Nuclear Antigens Human genes 0.000 description 1
- 108010051791 Nuclear Antigens Proteins 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 240000009002 Picea mariana Species 0.000 description 1
- 235000017997 Picea mariana var. mariana Nutrition 0.000 description 1
- 235000018000 Picea mariana var. semiprostrata Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001330459 Taxus wallichiana var. wallichiana Species 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 229940004858 usnic acid Drugs 0.000 description 1
- ICTZCAHDGHPRQR-UHFFFAOYSA-N usnic acid Natural products OC1=C(C)C(O)=C(C(C)=O)C2=C1C1(C)C(O)=C(C(=O)C)C(=O)C=C1O2 ICTZCAHDGHPRQR-UHFFFAOYSA-N 0.000 description 1
- WEYVVCKOOFYHRW-UHFFFAOYSA-N usninic acid Natural products CC12C(=O)C(C(=O)C)=C(O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O WEYVVCKOOFYHRW-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9733—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种极地抗衰组合物，旨在提供一种含有极地植物活性组分的具有显著保湿抗衰功效的组合物；其技术方案包括下述重量百分比的原料：挪威云杉叶提取物1‑10％，地衣提取物1‑10％，水解胶原0.2‑5％，透明质酸钠0.05‑1％，烟酰胺5‑15％，1，3‑丁二醇20‑45％，防腐剂0.1‑3.2％，水余量。属于化妆品技术领域。
Description
技术领域
本发明公开了一种抗衰组合物，具体地说，是一种极地抗衰组合物，属于化妆品技术领域。
背景技术
皮肤衰老是内在和外在两个因素共同影响的结果：内在因素主要是时间，外在因素主要是紫外线。内在衰老会导致皮肤细胞丧失储备能力，并限制皮肤应对环境给皮肤带来损伤的反应能力，此外还会导致皮肤变薄，从而皮肤对环境剪切力的抵抗能力降低；紫外线导致的皮肤衰老也称光老化，是除了时间老化外最显著的影响，皮肤每天暴露在低剂量的紫外线辐射下，会导致细胞核抗原增殖上调，DNA氧化损伤增加，日积月累，皮肤就会发生变化。
无论内源性和外源性的衰老都会受到氧化应激的影响。所谓氧化应激就是当体内活性氧的侵害程度超过机体抗氧化能力时，机体就无法完全清除氧化，导致细胞内产生大量氧化中间产物。氧化应激会直接作用于端粒，加速细胞衰老。
预防或减少皮肤老化的一个方法途径就是抗氧化。
目前市场上用于治疗皮肤老化的化妆品中活性成分主要是抗氧化剂，如视黄酸等。富含天然抗氧化剂的植物、藻类、真菌提取物被广泛应用于化妆品配方中。而在此方面最有潜力和吸引力的是生活在极端环境的生物，它们体内含有丰富的次级代谢物，例如类胡萝卜素、低温活性酶、蛋白质或抗氧化剂等，是潜力巨大的天然抗衰老原料来源。因此开发极端环境生物将是一个重要的创新源头和行之有效的途径。
极地指北极或南极极圈以内的地区，生长在该地区的植物称为极地植物。极地植物常年经受极端温度和强烈的紫外线，然而这种恶劣环境不但没有影响它们的生长，反而赋予了它们极强的抗压能力和高效的修护力，其所含细胞叶绿素和类胡萝卜素含量还会因此而增加，同时细胞中虾青素的含量显著提高，这强大的抗氧化功效正是其年复一年繁衍不息的能量所在，同时也让研究人员看到了它们在抗衰老产品中的巨大潜力。
目前极地植物中用于抗衰老的主要是极地雪藻，如专利CN110585247A公开了极地雪藻细胞裂解物在制备预防、延缓或治疗皮肤老化的药物或化妆品中的应用，其技术方案为使用有效量的极地雪藻细胞裂解物为活性成分，能够延缓皮肤老化，特别是由于氧化反应或者UV引起的皮肤老化，可以用于制备预防、延缓或治疗皮肤老化的药物或化妆品。然而由于需要使用的是极地雪藻细胞裂解物，所以需要新鲜的极地雪藻细胞，一般采用的方法是人工培养而不是自然采收，因此利用极地雪藻细胞需要模拟自然环境培养细胞，首先对设备和技术有一定要求，其次人工模拟的环境条件相比自然环境有差距，得到的极地雪藻细胞有效物质含量不如自然得到的丰富。
随着业界对极地植物抗氧化抗衰老能力的关注不断提升，一些其他极地植物在化妆品中的实际应用也逐渐提上日程。
综上，如何提供一种同时含有新兴的潜力巨大的极地植物成分和成熟的已知功效优良的人工合成化学物质形成一种高效抗衰老抗氧化保湿补水产品，具有实际商业意义和广阔应用前景。
发明内容
针对上述问题，本发明的目的是提供一种高效保湿、抗衰老极地抗衰组合物。
为此，本发明提供的技术方案是这样的：
一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物1-10％，地衣提取物1-10％，水解胶原0.2-5％，透明质酸钠0.05-1％，烟酰胺5-15％，1，3-丁二醇20-45％，防腐剂0.1-3.2％，水余量。
进一步的，上述的极地抗衰组合物，还包括重量百分比原料欧洲越桔果提取物0.5-5％。
进一步的，上述的极地抗衰组合物，还包括重量百分比原料玫瑰花提取物2-10％。
进一步的，上述的极地抗衰组合物，还包括重量百分比原料肌肽3-8％。
进一步的，上述的极地抗衰组合物，还包括重量百分比原料海水2-10％。
进一步的，上述的极地抗衰组合物，由下述重量百分比的原料组成：挪威云杉叶提取物2-10％，地衣提取物2-10％，水解胶原0.2-5％，透明质酸钠0.05-1％，烟酰胺5-15％，海水2-10％，欧洲越桔果提取物0.5-5％，玫瑰花提取物2-10％，肌肽3-8％，1，3-丁二醇20-45％，防腐剂0.1-3.2％，水余量。
进一步的，上述的极地抗衰组合物，由下述重量百分比的原料组成：挪威云杉叶提取物4-8％，地衣提取物4-8％，水解胶原1-4％，透明质酸钠0.1-0.8％，烟酰胺8-12％，海水4-8％，欧洲越桔果提取物1.5-3.5％，玫瑰花提取物4-8％，肌肽4-7％，1，3-丁二醇25-40％，防腐剂0.1-3.2％，水余量。
进一步的，上述的极地抗衰组合物，所述的防腐剂为戊二醇、己二醇、对羟基苯乙酮、苯甲酸钠、山梨酸钾、辛酰羟肟酸中的一种或多种。
进一步的，上述的极地抗衰组合物，所述的地衣提取物通过下述方法制备的：选用北极植物物种地衣，清洗、烘干、粉碎，直接蒸汽蒸馏，整个过程中北极植物物种地衣的温度≤100℃。原材料选取北极特有的植物物种地衣，地衣是真菌和水藻的共生体，具有极强的生命力。制备方法过程中，植物原材料被加热的温度不超过100℃，因此原材料中的成分不会进行热降解，可以得到很好的保留。
进一步的，上述的极地抗衰组合物，所述的挪威云杉叶提取物通过下述方法制备的：选用北极腹地加拿大北部生长的挪威云杉叶，清洗、烘干、粉碎，直接蒸汽蒸馏，整个过程中挪威云杉叶的温度≤100℃。原材料提取自北极腹地加拿大北部，严寒漫长的冬季，使得黑云杉分泌更多的营养成分。制备方法过程中，植物原材料被加热的温度不超过100℃，因此原材料中的成分不会进行热降解，可以得到很好的保留。
与现有技术相比，本发明提供的技术方案具有如下技术优点：
1、本发明提供的技术方案采用的挪威云杉叶提取物，地衣提取物，通过直接蒸汽蒸馏，整个过程中北极植物物种地衣的温度≤100℃，制备成相应提取物，有效的保留了极地植物原料的多种功效成分，应用在皮肤方面可以促进皮肤细胞的活力，能具有更强的消除自由基、提升皮肤细胞的再生能力，并具有很好的保湿抗衰、抗氧化功效。
2、本发明使用的挪威云杉叶提取物与地衣提取物相互复配，富含多种氨基酸、矿物质，松萝酸、地衣硬酸、木脂素、生物活性多酚等组成的多种缩合物，用于化妆品中具有清爽润滑易吸收、提升肌肤含水量、补充肌肤所需的多种矿物等效果。在此基础上复配透明质酸钠、水解胶原以及肌肽，可以进一步加强保湿、抗衰老的功效。
3、本发明提供的技术方案挪威云杉叶提取物、地衣提取物、透明质酸钠、水解胶原以及肌肽的基础上进一步复配欧洲越桔果提取物和玫瑰花提取物，富含丰富的花色苷、槲皮素、三萜类化合物、叶黄素、苹果酸、多种维生素、葡萄糖、果糖、柠檬酸等，能进一步增加抗氧化、延缓衰老，有效去除皱纹，同时具备抑菌、抗炎等功效。
具体实施方式
下面对本发明实施例中的技术方案进行清楚，完整地描述，显然，所描述的实施例仅仅是本发明的一部分实施例，而不是全部实施例。对于未特别注明的工艺参数或者条件，可参照常规技术进行。
实施例1
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物5％，地衣提取物5％，水解胶原2％，透明质酸钠0.2％，烟酰胺10％，海水5％，欧洲越桔果提取物2％，玫瑰花提取物5％，肌肽5％，1，3-丁二醇33％，防腐剂1％，水余量。
实施例2
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物4％，地衣提取物8％，水解胶原1％，透明质酸钠0.1％，烟酰胺12％，海水8％，欧洲越桔果提取物3.5％、玫瑰花提取物8％、肌肽4％，1，3-丁二醇40％，防腐剂3.2％，水余量。
实施例3
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物8％，地衣提取物4％，水解胶原4％，透明质酸钠0.8％，烟酰胺8％，海水4％，欧洲越桔果提取物1.5％、玫瑰花提取物4％、肌肽7％，1，3-丁二醇25％，防腐剂0.1％，水余量。
实施例4
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物7％，地衣提取物3％，水解胶原0.9％，透明质酸钠0.8％，烟酰胺7％，海水4％，欧洲越桔果提取物3.5％、玫瑰花提取物7％、肌肽4％，1，3-丁二醇35％，防腐剂2％，水余量。
实施例5
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物1％，地衣提取物10％，水解胶原0.2％，透明质酸钠0.05％，烟酰胺15％，海水10％，欧洲越桔果提取物0.5％、玫瑰花提取物2％、肌肽8％，1，3-丁二醇20％，防腐剂3.2％，水余量。
实施例6
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物10％，地衣提取物1％，水解胶原5％，透明质酸钠1％，烟酰胺5％，海水2％，欧洲越桔果提取物5％、玫瑰花提取物10％、肌肽3％，1，3-丁二醇45％，防腐剂0.1％，水余量。
实施例1-实施例6中所述的地衣提取物通过下述方法制备的：选用北极植物物种地衣，清洗、烘干、粉碎，直接蒸汽蒸馏，整个过程中北极植物物种地衣的温度≤100℃。
实施例1-实施例6中所述的挪威云杉叶提取物通过下述方法制备的：选用北极腹地加拿大北部生长的挪威云杉叶，清洗、烘干、粉碎，直接蒸汽蒸馏，整个过程中挪威云杉叶的温度≤100℃。
对比例1
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物5％，水解胶原2％，透明质酸钠0.2％，烟酰胺10％，海水5％，欧洲越桔果提取物2％，玫瑰花提取物5％，肌肽5％，1，3-丁二醇33％，防腐剂1％，水余量。
对比例2
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：地衣提取物5％，水解胶原2％，透明质酸钠0.2％，烟酰胺10％，海水5％，欧洲越桔果提取物2％，玫瑰花提取物5％，肌肽5％，1，3-丁二醇33％，防腐剂1％，水余量。
对比例3
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物5％，地衣提取物5％，透明质酸钠0.2％，烟酰胺10％，海水5％，欧洲越桔果提取物2％，玫瑰花提取物5％，肌肽5％，1，3-丁二醇33％，防腐剂1％，水余量。
对比例4
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：挪威云杉叶提取物5％，地衣提取物5％，水解胶原2％，烟酰胺10％，海水5％，欧洲越桔果提取物2％，玫瑰花提取物5％，肌肽5％，1，3-丁二醇33％，防腐剂1％，水余量。
对比例5
本发明提供的一种极地抗衰组合物，包括下述重量百分比的原料：普通挪威云杉叶提取物5％，普通地衣提取物5％，水解胶原2％，透明质酸钠0.2％，烟酰胺10％，海水5％，欧洲越桔果提取物2％，玫瑰花提取物5％，肌肽5％，1，3-丁二醇33％，防腐剂1％，水余量。
普通地衣提取物是通过下述方法制备的：选用普通植物物种地衣，清洗、烘干、粉碎，水分散，水蒸馏。制备方法过程中，部分植物成分，如酯类、酚类容易发生水解，原材料的成分得不到很好的保留。
普通挪威云杉叶提取是通过下述方法制备的：选用普通挪威云杉叶，清洗、烘干、粉碎，水分散，水蒸馏。制备方法过程中，部分植物成分，如酯类、酚类容易发生水解，因此原材料的成分得不到很好的保留。
效果证明实验
为了更好的证明本申请提供的技术方案的优点，下面给出本申请提供的技术方案效果证明实验：
1、实验方法：将实施例1～实施例6、对比例1～对比例5中的组合物分别用去离子水稀释10倍，并采用相同工艺制成面膜。随机抽取110名皮肤健康的志愿者进行测试，每10人一组，以每组为一单位，分别对应测试实施例1～实施例6、对比例1～对比例5的面膜样品。
各组志愿者按照QB/T2872-2007进行测试，每天睡前涂敷，连续30天，30天后收集各组志愿者的反馈数据，测试结果均取每组的平均值，整理结果，结果如表1～表3所示。
其中，皮肤的含水量采用经皮水测试仪测量；皮肤弹性采用德国CK公司的皮肤弹性测试仪MPA580，并使用Reviscometer RV600探头测得；皱纹、紧致度、细腻度以及光泽度均采用ANTSCI Visia皮肤检测仪测量；使用体验感评分根据使用者体验度进行评分；气血改善效果根据使用情况前后对比进行评分，总分均为10分，8～10分为良好，6～8分为一般，6分及以下为体验感差。
2、实验结果：见表1-表3
表1
表2
| 测试项目 | 皱纹明显改善/人数 | 皱纹轻微改善/人数 | 皱纹无改善/人数 |
| 实施例1 | 8 | 2 | 0 |
| 实施例2 | 9 | 1 | 0 |
| 实施例3 | 9 | 1 | 0 |
| 实施例4 | 10 | 0 | 0 |
| 实施例5 | 10 | 0 | 0 |
| 实施例6 | 7 | 3 | 0 |
| 对比例1 | 3 | 2 | 5 |
| 对比例2 | 4 | 1 | 5 |
| 对比例3 | 2 | 5 | 3 |
| 对比例4 | 5 | 4 | 1 |
| 对比例5 | 1 | 1 | 8 |
表3
以上数据结果表明，使用本发明提供的极地抗衰组合物实施例1～6制作面膜，对于改善皮肤弹性、气血、皱纹、紧致度、细腻度、光泽及补充皮肤水量具有显著效果，其中实施例5是最佳实施例。
与实施例相比，使用对比例1～5制作的面膜各方面护理效果都较差，无法满足高层次的皮肤护理需求。
上述实施例为本发明较佳的实施方式，但本发明的实施方式并不受上述实施例的限制，其他的任何未背离本发明的精神实质与原理下所作的改变，修饰，替代，组合，简化，均应为等效的置换方式，都包含在本发明的保护范围之内。
Claims (10)
1.一种极地抗衰组合物，其特征在于，包括下述重量百分比的原料：挪威云杉叶提取物1-10％，地衣提取物1-10％，水解胶原0.2-5％，透明质酸钠0.05-1％，烟酰胺5-15％，1，3-丁二醇20-45％，防腐剂0.1-3.2％，水余量。
2.根据权利要求1所述的一种极地抗衰组合物，其特征在于，还包括重量百分比原料欧洲越桔果提取物0.5-5％。
3.根据权利要求2所述的一种极地抗衰组合物，其特征在于，还包括重量百分比原料玫瑰花提取物2-10％。
4.根据权利要求3所述的一种极地抗衰组合物，其特征在于，还包括重量百分比原料肌肽3-8％。
5.根据权利要求4所述的一种极地抗衰组合物，其特征在于，还包括重量百分比原料海水2-10％。
6.根据权利要求1-5任一所述的一种极地抗衰组合物，其特征在于，由下述重量百分比的原料组成：挪威云杉叶提取物2-10％，地衣提取物2-10％，水解胶原0.2-5％，透明质酸钠0.05-1％，烟酰胺5-15％，海水2-10％，欧洲越桔果提取物0.5-5％，玫瑰花提取物2-10％，肌肽3-8％，1，3-丁二醇20-45％，防腐剂0.1-3.2％，水余量。
7.根据权利要求6所述的一种极地抗衰组合物，其特征在于，由下述重量百分比的原料组成：挪威云杉叶提取物4-8％，地衣提取物4-8％，水解胶原1-4％，透明质酸钠0.1-0.8％，烟酰胺8-12％，海水4-8％，欧洲越桔果提取物1.5-3.5％，玫瑰花提取物4-8％，肌肽4-7％，1，3-丁二醇25-40％，防腐剂0.1-3.2％，水余量。
8.根据权利要求1所述的一种极地抗衰组合物，其特征在于，所述的防腐剂为戊二醇、己二醇、对羟基苯乙酮、苯甲酸钠、山梨酸钾、辛酰羟肟酸中的一种或多种。
9.根据权利要求1所述的一种极地抗衰组合物，其特征在于，所述的地衣提取物通过下述方法制备的：采用北极植物物种地衣，清洗、烘干、粉碎，直接蒸汽蒸馏，整个过程中北极植物物种地衣的温度≤100℃。
10.根据权利要求1所述的一种极地抗衰组合物，其特征在于，所述的挪威云杉叶提取物通过下述方法制备的：采用北极腹地加拿大北部生长的挪威云杉叶，清洗、烘干、粉碎，直接蒸汽蒸馏，整个过程中挪威云杉叶的温度≤100℃。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211417613.6A CN115624509A (zh) | 2022-11-11 | 2022-11-11 | 一种极地抗衰组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211417613.6A CN115624509A (zh) | 2022-11-11 | 2022-11-11 | 一种极地抗衰组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115624509A true CN115624509A (zh) | 2023-01-20 |
Family
ID=84910240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211417613.6A Pending CN115624509A (zh) | 2022-11-11 | 2022-11-11 | 一种极地抗衰组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115624509A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102224131A (zh) * | 2008-11-10 | 2011-10-19 | 韩国海洋研究院 | 新化合物ramalin及其应用 |
| KR20160036236A (ko) * | 2014-09-25 | 2016-04-04 | 주식회사 네이처인랩 | 극지 지의류 추출물을 함유하는 자외선 차단제 조성물 및 이를 함유하는 기능성 화장품 |
| CN110917051A (zh) * | 2019-11-07 | 2020-03-27 | 泉后(广州)生物科技研究院有限公司 | 一种美白精华液及其制备方法 |
| CN113827519A (zh) * | 2021-10-11 | 2021-12-24 | 科丝美诗(中国)化妆品有限公司 | 一种具有美白功效的特殊外观啫喱及其制备方法 |
-
2022
- 2022-11-11 CN CN202211417613.6A patent/CN115624509A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102224131A (zh) * | 2008-11-10 | 2011-10-19 | 韩国海洋研究院 | 新化合物ramalin及其应用 |
| KR20160036236A (ko) * | 2014-09-25 | 2016-04-04 | 주식회사 네이처인랩 | 극지 지의류 추출물을 함유하는 자외선 차단제 조성물 및 이를 함유하는 기능성 화장품 |
| CN110917051A (zh) * | 2019-11-07 | 2020-03-27 | 泉后(广州)生物科技研究院有限公司 | 一种美白精华液及其制备方法 |
| CN113827519A (zh) * | 2021-10-11 | 2021-12-24 | 科丝美诗(中国)化妆品有限公司 | 一种具有美白功效的特殊外观啫喱及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104814900B (zh) | 一种美白组合物及其制备方法 | |
| KR101353054B1 (ko) | 고로쇠 나무와 황칠 나무를 이용한 발효물 및 이의 제조방법 그리고 이를 이용한 식품 조성물 및 화장료 조성물 | |
| KR101881319B1 (ko) | 흑효모균 및 유산균을 이용하여 발효한 인삼열매 발효물을 함유하는 화장료 조성물 | |
| KR20120056594A (ko) | 모자반 추출물, 청각 추출물 및 참미역 추출물을 함유하는 화장료 조성물 | |
| CN117180332B (zh) | 用于改善修复皮肤的樟树叶提取物及其提取方法和用途 | |
| CN108042436B (zh) | 蓝铜胜肽抗衰保湿精华霜 | |
| CN109481390A (zh) | 一种具有保湿、美白、抗衰作用的组合成分及其应用 | |
| KR20070096163A (ko) | 아토피 피부용 조성물 | |
| CN107802576A (zh) | 一种天然动植物细胞补充剂及其制备方法 | |
| CN108815100A (zh) | 含有艾叶干细胞提取物的抑菌止痒护肤品及其制备方法 | |
| KR101421537B1 (ko) | 다시마 아임계수 추출물을 유효성분으로 포함하는 화장료 조성물 | |
| CN115624509A (zh) | 一种极地抗衰组合物 | |
| KR101587077B1 (ko) | 피부 생리활성을 가지는 백년초 발효물을 포함하는 조성물 | |
| CN110075029A (zh) | 一种涂抹式青梅抗氧化面膜及其制备方法 | |
| KR20200054590A (ko) | 미강 발효 고형분을 유효성분으로 함유한 피부 장벽 강화용 화장료 조성물 | |
| CN107496251A (zh) | 一种含有芍药干细胞提取物的美白护肤品 | |
| CN110354050B (zh) | 一种延缓衰老组合物、制备方法及其应用 | |
| CN105982828A (zh) | 益智护肤精油及其制备方法和应用 | |
| KR101749330B1 (ko) | 목이버섯이 배양된 황칠나무의 추출물을 유효성분으로 함유하는 화장품 조성물 | |
| WO2020075074A1 (en) | Aqueous extract from cells of fitzroya cupressoides (alerce) with anti-aging and skin regeneration properties | |
| CN109646381A (zh) | 一种添加有植物提取物的润肤乳液及其制备方法 | |
| KR20210065591A (ko) | 부아메라열매오일과 클로브꽃추출물을 유효성분으로 포함하는 기능성 화장료 조성물 | |
| KR102364428B1 (ko) | 항산화 활성이 우수한 8종 곡물 발효추출물을 함유하는 피부 개선용 화장료 조성물 | |
| CN113633591B (zh) | 一种美白组合物、制备方法及应用 | |
| CN111297763B (zh) | 一种具有美白淡斑功效的组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20230120 |